Transcription co-activator P300 activates Elk1-aPKC-ι signaling mediated epithelial-to-mesenchymal transition and malignancy in hepatocellular carcinoma.

Oncogenesis
Chaoqun MaJianming Wang

Abstract

Epithelial-to-mesenchymal transition (EMT) plays an important role in invasion and metastasis of hepatocellular carcinoma (HCC). Our previous study found that atypical protein kinase C-ι (aPKC-ι) promoted the EMT process in HCC. However, how the aPKC-ι signaling pathway is regulated in HCC has not been elucidated. In this study, vector transfection was utilized to study the invasion of HCC cells, and the mechanism between P300 and aPKC-ι signaling pathways in regulating the EMT process of HCC was further elucidated in vitro and in vivo. We found both P300 and aPKC-ι were highly expressed in HCC and they were correlated with tumor progression and poor survival in HCC patients. P300 knockdown inhibited EMT, invasion and other malignant events of HCC cells but promoted cell apoptosis and cycle arrest. However, the effects mediated by P300 knockdown were abolished by aPKC-ι overexpression. Further studies showed that P300 upregulates aPKC-ι expression through increasing the transcription of Elk1, a transcriptional activator of aPKC-ι, and stabilizing Elk1 protein and its phosphorylation. In conclusion, our work uncovered the molecular mechanism by which oncogenic aPKC-ι is upregulated in HCC and suggests that P300, like aPKC-ι, may...Continue Reading

References

Mar 30, 2001·The Journal of Biological Chemistry·N Vo, R H Goodman
Jan 9, 2003·Current Opinion in Cell Biology·Sandrine Etienne-Manneville, Alan Hall
Dec 13, 2003·The Journal of Biological Chemistry·W Clay GustafsonAlan P Fields
Aug 18, 2004·Biochemical Pharmacology·Eric Kalkhoven
Aug 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·Astrid M EderGordon B Mills
Aug 24, 2005·Oncogene·Yan-Nan LiuJi Hshiung Chen
Jun 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sarada L NandiwadaDaniel L Mueller
Apr 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Daniel P TeufelAlan R Fersht
Jun 16, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Alan P Fields, Roderick P Regala
Jul 28, 2007·The Journal of Biological Chemistry·Mete ErdoganRoy Zent
Dec 23, 2008·The Journal of Surgical Research·Jian-Ming WangSheng-Quan Zou
Jul 2, 2009·International Journal of Cancer. Journal International Du Cancer·Soeren Torge MeesJoerg Haier
Oct 13, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Muh-Hwa YangJaw-Ching Wu
Oct 27, 2009·Future Oncology·Franziska van ZijlWolfgang Mikulits
Dec 1, 2009·Cell·Jean Paul ThieryM Angela Nieto
Jan 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Richard S Finn
Oct 15, 2010·Journal of Cellular Physiology·Nicole R MurrayAlan P Fields
May 18, 2011·Annals of Surgical Oncology·Yan-Ming ZhouJia-Mei Yang
Feb 23, 2012·Lancet·Alejandro FornerJordi Bruix
Nov 16, 2013·Biochemical Pharmacology·Peter J ParkerAlan P Fields
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Mar 28, 2017·Breast Cancer Research and Treatment·Muhammad AsaduzzamanErnesto Yagüe
Jun 3, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yawei QianJianming Wang

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
transfection
Co-IP
immunoprecipitation
Ch-IP
co-immunoprecipitation
xenograft
xenografts
dissection
protein assay

Software Mentioned

ModFit

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.